Clinical Trial Update: Trial in Patients With Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Reports the completion of a Phase 2 trial in relapsed ovarian cancer conducted by the Nordic Society of Gynaecological Oncology - Clinical Trials Unit.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED